• Decrease font size
  • Default font           size
  • Increase font size

Medicines

inhaler-and-tablets-150Prosonix is the world leader in use of ultrasonic pharmaceutical particle engineering technologies for the manufacture of high value pharmaceutical powders and structured drug products. Our pipeline addresses the fast-growing market sectors of asthma, COPD and other respiratory disorders, as well as niche opportunities in orally and parentally delivered products. Prosonix proprietary technologies can be used for API manufacture at any scale.

Particles

particles-168-145Prosonitron™, DISCUS®, UMAX®, SAX™ and PRT based process technologies are proprietary “Solution-to-Particle” methods for controlling crystal size, shape and polymorph for APIs and excipients. Technologies offer dose-to-dose uniformity, formulation consistency, stability and 200% performance increase of inhaled APIs compared to micronized. Combination particles of multiple APIs can be manufactured.

Ultrasound

UltrasoundPower ultrasound facilitates controlled and reproducible crystal nucleation which is fundamental in controlling crystallization. Sonocrystallization delivers controlled nucleation and superior control of particle size, morphology, polymorphism, crystallinity and purity, and in doing so helps eliminate the need for troublesome external seeding and micronization for inhaled medicines.

SonoLab

sl250-cutaway-150-89Multipurpose laboratory equipment for sonocrystallization & sonochemistry are now available. These highly effective and flexible research tools facilitate 100ml – 100L operational capability in batch or continuous operation and can be integrated with automated laboratory reactors. The unique designs allow seamless transition and scale up to Prosonitron™ technology for commercial scale operation.

Prosonitron

prosonitron-500-1-atex-150Prosonix provide cGMP & ATEX sonocrystallization Prosonitron™ ultrasonic process and reactor technology. They are aligned with emergent FDA “QbD” and “Design for Intent” philosophy. Our proprietary systems are of modular design for optimum flexibility and are an easy retro-fit to existing equipment. They are proven across scale in API production and can be seen as sustainable green technology.

Prosonix World Leader in Ultrasonic Particle Engineering for Better Medicines PDF Print E-mail
Written by Graham Ruecroft   
Tuesday, 12 January 2010 00:00

Prosonix is the world leader in the commercialization of proprietary ultrasonic pharmaceutical particle engineering technologies employed in the manufacture of many high value pharmaceutical powders and ultimately better structured drug products.

asthma_cr_150Based in Oxford UK, our teams of pharmaceutical scientists and technologists combine to give Prosonix a unique multidisciplinary approach to solving complex pharmaceutical solid-state problems. Prosonix leverages its proprietary intellectual property, patented bespoke equipment, and technologies to deliver long term and sustainable value.

spherical-UMAX-particles-150-112Prosonix is developing a portfolio of engineered pharmaceutical mono and combination inhalation therapy products that offer distinct and significant therapeutic advantages to patients compared with commercial products. 

 

tablets_150Our innovative pipeline addresses the large and fast-growing market sectors of asthma, COPD and other respiratory disorders, as well as niche opportunities for a number of novel orally and parentally delivered products.

Partner with Prosonix today

Last Updated on Tuesday, 12 January 2010 11:23
 
Prosonix Wins Award at Major Conference- DDL-20 PDF Print E-mail
Written by Graham Ruecroft   
Sunday, 13 December 2009 00:00

ddl20-gala dipesh parikh_cr 150 x125

 

Prosonix was delighted to win the best industrial poster award at Europe's premier conference and exhibition dedicated to pulmonary and nasal drug delivery, namely Drug Delivery to the Lungs - DDL20, which took place from Wednesday 9th - Friday 11th  December 2009, in its 20th year!
Attachments:
FileFile size
Download this file (DDL20 poster handout.pdf)DDL-20 Winning Poster1707 Kb
Download this file (Press Release DDL~20 Award 21 December 2009.pdf)Press Release DDL Award 2009114 Kb
Last Updated on Sunday, 24 January 2010 12:41
Read more...
 
Prosonix and Aeropharm Announce Agreement PDF Print E-mail
Written by Graham Ruecroft   
Friday, 19 December 2008 12:35
inhaler-150-112Prosonix Ltd (Oxford, UK) is delighted to announce a new agreement for the application of its proprietary ultrasonic particle engineering technology in the pharmaceutical industry. This new agreement has been concluded with Aeropharm (Rudolstadt, Germany) and is concerned with the development and manufacture of a new generation of "difficult-to-make" generic products.
Attachments:
FileFile size
Download this file (PROSONIX AND AEROPHARM FINAL.pdf)Prosonix & Aeropharm announcement43 Kb
Last Updated on Tuesday, 03 February 2009 22:14
Read more...
 
Prosonix Attains International Quality Approval PDF Print E-mail
Written by Graham Ruecroft   
Friday, 26 June 2009 08:02

sgt_iso 9001-2008_tcl_150-143Prosonix (Oxford, UK) is pleased to announce that it has achieved accreditation to the Quality Management standard ISO 9001:2008 following a recent audit of business systems and procedures by independent external auditors SGS (UK) Ltd.

 

Attachments:
FileFile size
Download this file (Press Release ISO9000 26 June 2009.pdf)Press Release ISO9000 26 June 2009.pdf64 Kb
Last Updated on Friday, 26 June 2009 10:51
Read more...
 
Pfizer Selects Prosonix Crystallization Technology PDF Print E-mail
Written by Christian Jones   
Friday, 19 December 2008 11:47
recirculation-prosonitron-150-199Prosonix Ltd (Oxford, UK) is delighted to announce that Pfizer Global Manufacturing will implement Prosonix’ Prosonitron reactor and sonocrystallization process technology at Pfizer’s manufacturing facilities in Ireland.
Attachments:
FileFile size
Download this file (PROSONIX AND PFZER  PRESS RELEASE FINAL 16 SEPTEMBER 2008 PR.pdf)Pfizer press release101 Kb
Last Updated on Tuesday, 03 February 2009 22:15
Read more...
 

Events

Newsflash

Prosonix (Oxford, UK) is pleased to announce that it has achieved accreditation to the Quality Management standard ISO 9001:2008 following a recent audit of business systems and procedures by independent external auditors SGS (UK) Ltd.

Who's Online

Now 3 guests online

Login Form




Prosonix Key Concepts

ISO9000 accreditation

iso9000